1. Home
  2. EQBK vs PCRX Comparison

EQBK vs PCRX Comparison

Compare EQBK & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equity Bancshares Inc.

EQBK

Equity Bancshares Inc.

HOLD

Current Price

$48.35

Market Cap

870.8M

Sector

Finance

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$20.57

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQBK
PCRX
Founded
2002
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
870.8M
1.0B
IPO Year
2015
2011

Fundamental Metrics

Financial Performance
Metric
EQBK
PCRX
Price
$48.35
$20.57
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$48.80
$35.33
AVG Volume (30 Days)
77.0K
1.0M
Earning Date
01-21-2026
02-26-2026
Dividend Yield
1.47%
N/A
EPS Growth
N/A
N/A
EPS
1.23
0.47
Revenue
$199,739,000.00
$716,791,000.00
Revenue This Year
$76.92
$6.21
Revenue Next Year
$4.99
$8.26
P/E Ratio
$39.76
$44.07
Revenue Growth
N/A
3.14
52 Week Low
$34.11
$18.80
52 Week High
$50.07
$27.64

Technical Indicators

Market Signals
Indicator
EQBK
PCRX
Relative Strength Index (RSI) 56.42 36.28
Support Level $46.31 $18.80
Resistance Level $50.07 $21.12
Average True Range (ATR) 1.24 1.26
MACD 0.17 -0.43
Stochastic Oscillator 50.13 23.31

Price Performance

Historical Comparison
EQBK
PCRX

About EQBK Equity Bancshares Inc.

Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: